Work

MS4A3 Improves Imatinib Response and Survival in BCR-ABL1 Primary TKI Resistance and in Blastic Transformation of Chronic Myeloid Leukemia

Year: 2015

Type: article

Source: Blood

DOI: 10.1182/blood.v126.23.14.14

Authors: Anna M. Eiring, Jamshid S. Khorashad, Anupriya Agarwal, Clinton C. Mason, Fan Yu, Hannah M. Redwine, Amber D. Bowler, Kevin C. Gantz, Kimberly R. Reynolds, Phillip M. Clair, David J. Anderson, Srinivas K Tantravahi, Shannon K. McWeeney, Brian J. Druker, Derek L. Stirewalt, Vivian G. Oehler, Thomas O'Hare, Michael W. Deininger

Institutions: University of Utah, Huntsman Cancer Institute, Oregon Health & Science University, OHSU Knight Cancer Institute, Fred Hutch Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2531133168

FWCI: 0.227

Cites:

Cited by: 2

Related to: 10